News | July 10, 2007

Baptist Launches Video on Preventing Sudden Cardiac Death

July 11, 2007 - Baptist Cardiovascular Services launches a video interview with Cardiac Electrophysiologist Drew Pickett, M.D., on how implanting a defibrillator can help reduce sudden cardiac death, after a study sponsored by Medtronic Inc. and Wyeth shows that ICDs are a cost-effective therapy.
Also, Dr. Pickett talks about the SCD-HeFT Trial, which is the most recent and largest clinical study to decide who benefits from a defibrillator. Findings from the trial show that ICDs used preventively in people with heart failure and poor heart pumping function have the potential to save more than 350,000 lives annually. These results reinforce evidence from earlier trials and the Centers for Medicare and Medicaid Services (CMS) has extended reimbursement to Medicare patients eligible for ICD therapy based on the SCD-HeFT clinical study results.
Funded by manufacturer Medtronic and drug maker Wyeth, the study intends to show that ICDs are a cost-effective therapy in this heart failure population and reinforces the fact that defibrillation is the only treatment that can stop a life-threatening heart rhythm once it occurs.

For more information: www.mbhs.org/med_serv/heart/index.htm

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init